CRISPR

CRISPR4-tet2

ID
ZDB-CRISPR-220126-5
Name
CRISPR4-tet2
Previous Names
None
Target
Sequence
5' - CCCAAACATAACAAGGCAG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
hsi12 tet2
Expression
Gene expression in Wild Types + CRISPR4-tet2
No data available
Phenotype
Phenotype resulting from CRISPR4-tet2
No data available
Phenotype of all Fish created by or utilizing CRISPR4-tet2
Phenotype Fish Conditions Figures
erythrocyte differentiation decreased process quality, abnormal tet2hsi12/hsi12 standard conditions Fig. 3 from Rajan et al., 2021
erythroid progenitor cell decreased amount, abnormal tet2hsi12/hsi12 standard conditions Fig. 3 from Rajan et al., 2021
myeloid lineage restricted progenitor cell decreased amount, abnormal tet2hsi12/hsi12 standard conditions Fig. 2 from Rajan et al., 2021
whole organism hbbe1.1 expression decreased amount, abnormal tet2hsi12/hsi12 standard conditions Fig. 3 from Rajan et al., 2021
neutrophilic promyelocyte cebp1 expression increased distribution, abnormal tet2hsi12/hsi12 chemical treatment by injection: ManNAz-DBCO-Pam3CSK4 Fig. 7 from Rajan et al., 2021
whole organism hbae1.1 expression decreased amount, abnormal tet2hsi12/hsi12 standard conditions Fig. 3 from Rajan et al., 2021
myeloid cell spi1b expression decreased distribution, abnormal tet2hsi12/hsi12 standard conditions Fig. 2 from Rajan et al., 2021
myeloid lineage restricted progenitor cell spi1b expression decreased distribution, abnormal tet2hsi12/hsi12 standard conditions Fig. 2 from Rajan et al., 2021
myeloid cell cpa5 expression decreased distribution, abnormal tet2hsi12/hsi12 standard conditions Fig. 2 from Rajan et al., 2021
head kidney myeloid cell dysplastic, abnormal tet2hsi12/hsi12 standard conditions Fig. 4 from Rajan et al., 2021
whole organism cdkn1a expression increased amount, abnormal tet2hsi12/hsi12 chemical treatment by environment: camptothecin Fig. 6 from Rajan et al., 2021
myeloblast cebp1 expression increased distribution, abnormal tet2hsi12/hsi12 chemical treatment by injection: ManNAz-DBCO-Pam3CSK4 Fig. 7 from Rajan et al., 2021
neutrophilic myelocyte cebp1 expression increased distribution, abnormal tet2hsi12/hsi12 chemical treatment by injection: ManNAz-DBCO-Pam3CSK4 Fig. 7 from Rajan et al., 2021
myeloid cell differentiation decreased process quality, abnormal tet2hsi12/hsi12 standard conditions Fig. 2 from Rajan et al., 2021
neutrophil mpx expression decreased distribution, abnormal tet2hsi12/hsi12 standard conditions Fig. 2 from Rajan et al., 2021
erythroid progenitor cell gata1a expression decreased distribution, abnormal tet2hsi12/hsi12 standard conditions Fig. 3 from Rajan et al., 2021
whole organism ab11-tp53 labeling increased amount, abnormal tet2hsi12/hsi12 standard conditions Fig. 6 from Rajan et al., 2021
whole organism decreased length, abnormal tet2hsi12/hsi12 standard conditions Fig. 1 from Rajan et al., 2021
head kidney erythroid lineage cell dysplastic, abnormal tet2hsi12/hsi12 standard conditions Fig. 4 from Rajan et al., 2021
head kidney hematopoietic cell dysplastic, abnormal tet2hsi12/hsi12 standard conditions Fig. 4 from Rajan et al., 2021
myeloid cell decreased amount, abnormal tet2hsi12/hsi12 standard conditions Fig. 2 from Rajan et al., 2021
leukocyte lcp1 expression decreased distribution, abnormal tet2hsi12/hsi12 standard conditions Fig. 2 from Rajan et al., 2021
whole organism gata1a expression decreased amount, abnormal tet2hsi12/hsi12 standard conditions Fig. 3 from Rajan et al., 2021
leukocyte decreased amount, abnormal tet2hsi12/hsi12 standard conditions Fig. 2 from Rajan et al., 2021
whole organism bbc3 expression increased amount, abnormal tet2hsi12/hsi12 chemical treatment by environment: camptothecin Fig. 6 from Rajan et al., 2021
whole organism hbae3 expression decreased amount, abnormal tet2hsi12/hsi12 standard conditions Fig. 3 from Rajan et al., 2021
neutrophil decreased amount, abnormal tet2hsi12/hsi12 standard conditions Fig. 2 from Rajan et al., 2021
Citations